NasdaqGS:NOVTElectronic
Why Novanta (NOVT) Is Up 16.7% After Q2 Results And Its Largest Medical Acquisition
In the past week, Novanta Inc. reported second-quarter 2026 results showing sales of US$265.81 million and net income of US$12.54 million, alongside higher earnings per share versus a year earlier and updated guidance that now includes its newly closed Riverpoint Medical acquisition.
The Riverpoint Medical deal, Novanta’s largest acquisition to date, meaningfully increases its exposure to medical end markets and recurring consumables, potentially reshaping the company’s business mix and...